Literature DB >> 23180818

Phosphatidylinositol 3-kinase-γ signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice.

Xiaolun Sun1, Bo Liu, Ryan Balfour Sartor, Christian Jobin.   

Abstract

Crypt abscesses caused by excessive neutrophil accumulation are prominent features of human campylobacteriosis and its associated pathology. The molecular and cellular events responsible for this pathological situation are currently unknown. We investigated the contribution of PI3K-γ signaling in Campylobacter jejuni-induced neutrophil accumulation and intestinal inflammation. Germ-free and specific pathogen-free Il10(-/-) and germ-free Il10(-/-);Rag2(-/-) mice were infected with C. jejuni (10(9) CFU/mouse). PI3K-γ signaling was manipulated using either the pharmacological PI3K-γ inhibitor AS252424 (i.p. 10 mg/kg daily) or genetically using Pi3k-γ(-/-) mice. After up to 14 d, inflammation was assessed histologically and by measuring levels of colonic Il1β, Cxcl2, and Il17a mRNA. Neutrophils were depleted using anti-Gr1 Ab (i.p. 0.5 mg/mouse/every 3 d). Using germ-free Il10(-/-);Rag2(-/-) mice, we observed that innate immune cells are the main cellular compartment responsible for campylobacteriosis. Pharmacological blockade of PI3K-γ signaling diminished C. jejuni-induced intestinal inflammation, neutrophil accumulation, and NF-κB activity, which correlated with reduced Il1β (77%), Cxcl2 (73%), and Il17a (72%) mRNA accumulation. Moreover, Pi3k-γ(-/-) mice pretreated with anti-IL-10R were resistant to C. jejuni-induced intestinal inflammation compared with Wt mice. This improvement was accompanied by a reduction of C. jejuni translocation into the colon and extraintestinal tissues and by attenuation of neutrophil migratory capacity. Furthermore, neutrophil depletion attenuated C. jejuni-induced crypt abscesses and intestinal inflammation. Our findings indicate that C. jejuni-induced PI3K-γ signaling mediates neutrophil recruitment and intestinal inflammation in Il10(-/-) mice. Selective pharmacological inhibition of PI3K-γ may represent a novel means to alleviate severe cases of campylobacteriosis, especially in antibiotic-resistant strains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180818      PMCID: PMC3529774          DOI: 10.4049/jimmunol.1201825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

2.  Role of phosphatidylinositol 3-kinase-gamma in mediating lung neutrophil sequestration and vascular injury induced by E. coli sepsis.

Authors:  Evan Ong; Xiao-Pei Gao; Dan Predescu; Michael Broman; Asrar B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-09-23       Impact factor: 5.464

3.  Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus.

Authors:  F Snijders; E J Kuijper; B de Wever; L van der Hoek; S A Danner; J Dankert
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

4.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

Review 5.  Epidemiologic and clinical features of Campylobacter jejuni infections.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

6.  Unique features of a highly pathogenic Campylobacter jejuni strain.

Authors:  Dirk Hofreuter; Jennifer Tsai; Robert O Watson; Veronica Novik; Bill Altman; Michelle Benitez; Christina Clark; Clotilde Perbost; Thomas Jarvie; Lei Du; Jorge E Galán
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  Acute colitis caused by Campylobacter fetus ss. jejuni.

Authors:  M J Blaser; R B Parsons; W L Wang
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

8.  Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.

Authors:  P G Oomes; B C Jacobs; M P Hazenberg; J R Bänffer; F G van der Meché
Journal:  Ann Neurol       Date:  1995-08       Impact factor: 10.422

9.  A point-source outbreak of campylobacteriosis associated with consumption of raw milk.

Authors:  J A Korlath; M T Osterholm; L A Judy; J C Forfang; R A Robinson
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

10.  Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species.

Authors:  Derrick E Fouts; Emmanuel F Mongodin; Robert E Mandrell; William G Miller; David A Rasko; Jacques Ravel; Lauren M Brinkac; Robert T DeBoy; Craig T Parker; Sean C Daugherty; Robert J Dodson; A Scott Durkin; Ramana Madupu; Steven A Sullivan; Jyoti U Shetty; Mobolanle A Ayodeji; Alla Shvartsbeyn; Michael C Schatz; Jonathan H Badger; Claire M Fraser; Karen E Nelson
Journal:  PLoS Biol       Date:  2005-01-04       Impact factor: 8.029

View more
  20 in total

1.  Induction of neutrophil extracellular traps by Campylobacter jejuni.

Authors:  Sean Callahan; Ryan S Doster; Joseph W Jackson; Brittni R Kelley; Jennifer A Gaddy; Jeremiah G Johnson
Journal:  Cell Microbiol       Date:  2020-05-21       Impact factor: 3.715

2.  Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice.

Authors:  Xiaolun Sun; Kathryn Winglee; Raad Z Gharaibeh; Josee Gauthier; Zhen He; Prabhanshu Tripathi; Dorina Avram; Steven Bruner; Anthony Fodor; Christian Jobin
Journal:  Gastroenterology       Date:  2018-02-01       Impact factor: 22.682

Review 3.  Protein kinases are potential targets to treat inflammatory bowel disease.

Authors:  Lei Yang; Yutao Yan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-11-06

4.  Vaccines Using Clostridium perfringens Sporulation Proteins Reduce Necrotic Enteritis in Chickens.

Authors:  Ying Fu; Mohit Bansal; Tahrir Alenezi; Ayidh Almansour; Hong Wang; Xiaolun Sun
Journal:  Microorganisms       Date:  2022-05-27

5.  Murine Models for the Investigation of Colonization Resistance and Innate Immune Responses in Campylobacter Jejuni Infections.

Authors:  Soraya Mousavi; Stefan Bereswill; Markus M Heimesaat
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

6.  Nucleotide-binding oligomerization domain-containing protein 2 controls host response to Campylobacter jejuni in Il10-/- mice.

Authors:  Xiaolun Sun; Christian Jobin
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

Review 7.  The Host Cellular Immune Response to Infection by Campylobacter Spp. and Its Role in Disease.

Authors:  Sean M Callahan; Carolina G Dolislager; Jeremiah G Johnson
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

8.  The fibronectin-binding motif within FlpA facilitates Campylobacter jejuni adherence to host cell and activation of host cell signaling.

Authors:  Charles L Larson; Derrick R Samuelson; Tyson P Eucker; Jason L O'Loughlin; Michael E Konkel
Journal:  Emerg Microbes Infect       Date:  2013-10-09       Impact factor: 7.163

9.  Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity.

Authors:  A Malik; D Sharma; J St Charles; L A Dybas; L S Mansfield
Journal:  Mucosal Immunol       Date:  2013-11-13       Impact factor: 7.313

Review 10.  Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract.

Authors:  James A Cotton; Christina B Amat; Andre G Buret
Journal:  Pathogens       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.